Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means
A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.
- Fuente
- Decrypt
- Publicado
- 2026-08-19 16:54 UTC
- Cache actualizado
- 2026-08-19 17:01 UTC
Esta página solo muestra el título, el resumen y los datos de la fuente.
Abrir original ↗Comprobar comisionesTemas relacionados
01Users and Apps02Market and Policy
Decrypt
Follow consumer wallet, application, security, DeFi, and market updates before deciding whether Energy rental is needed.
Crypto Market, Regulation, and Stablecoin Policy News
Track crypto market, regulatory, stablecoin, and major-asset updates for broader blockchain context.